Michael E. Carney - Concepedia

Author

Michael E. Carney

Also Known As

Annika Lindblom, Benito Campos, Carney, Michael E., Chanock, Stephen, Galina Lurie, Goode, Ellen L., Ingo Runnebaum, Jonathan Beesley, Lynne R. Wilkens, M E Carney

Publications

6.1K

Citations

H-Index

Concepts

All Affiliations

University of Hawaiʻi at Mānoa University of Hawaii System Cancer Center of Hawaii Cancer Research Center QIMR Berghofer Medical Research Institute

About

Michael E. Carney is an author at University of Hawaiʻi at Mānoa specializing in medicine, obstetrics, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	1.8K
2	Public Health	6	6	396
3	Engineering	2	2	1.1K
4	Health Sciences	1	1	170
5	Natural Sciences	1	1	182

Michael E. Carney

Publications

Citations

H-Index

Page 1

	Year	Citations
Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case–control studies Celeste Leigh Pearce, Claire Templeman, Mary Anne Rossing, The Lancet Oncology	2012	912
Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines Kyle Ellrott, Matthew H. Bailey, Gordon Saksena, Cell Systems EngineeringGeneticsGenomicsArtifact FilteringTcga Data	2018	895
Direct Projections from the Central Amygdaloid Nucleus to the Hypothalamic Paraventricular Nucleus: Possible Role in Stress-Induced Adrenocorticotropin Release Thackery S. Gray, Michael E. Carney, Debra J. Magnuson Neuroendocrinology	1989	331
PTEN mutation in endometrial cancers is associated with favorable clinical and pathologic characteristics. John I. Risinger, Kelly S. Hayes, G. Larry Maxwell, PubMed MedicinePten MutationPathologyGynecologyPten Mutations	1998	284
Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium Catherine M. Olsen, Christina M. Nagle, David C. Whiteman, Endocrine Related Cancer	2013	227
Opposing effects of cancer-type-specific SPOP mutants on BET protein degradation and sensitivity to BET inhibitors Hana Janoušková, Geniver El Tekle, Elisa Bellini, Nature Medicine Protein FunctionEngineeringProtein ExpressionOncogenic AgentBet Protein Degradation	2017	182
Frequency of germline and somatic BRCA1 mutations in ovarian cancer. Andrew Berchuck, Keegan Heron, Michael E. Carney, PubMed Brca1 MutationsSomatic VariantTumor HeterogeneityMedicineGenetics	1998	170
<i>ESR1/SYNE1</i> Polymorphism and Invasive Epithelial Ovarian Cancer Risk: An Ovarian Cancer Association Consortium Study Jennifer A. Doherty, Mary Anne Rossing, Kara L. Cushing‐Haugen, Cancer Epidemiology Biomarkers & Prevention Epithelial Ovarian CancerGeneticsGenetic EpidemiologyHuman PolymorphismGynecology	2010	111
<i>Vitamin D Receptor</i>Gene Polymorphisms and Epithelial Ovarian Cancer Risk Galina Lurie, Lynne R. Wilkens, Pamela J. Thompson, Cancer Epidemiology Biomarkers & Prevention Epidemiology Of CancerGenetic EpidemiologyReproductive HealthPathologyGynecology	2007	93
Consortium analysis of 7 candidate SNPs for ovarian cancer Susan J. Ramus, Robert A. Vierkant, Sharon E. Johnatty, International Journal of Cancer	2008	89

Page 1